These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 31721637)

  • 1. Utilization of a Transanal TME Platform to Enable a Distal TME Dissection En Bloc with Presacral Fascia and Pelvic Sidewall with Intraoperative Radiotherapy Delivery in a Locally Advanced Rectal Cancer: Advanced Application of taTME.
    Waters PS; Peacock O; Larach T; Lee JD; McCormick JJ; Chander S; Heriot AG; Warrier SK
    J Laparoendosc Adv Surg Tech A; 2020 Jan; 30(1):53-57. PubMed ID: 31721637
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer.
    Caycedo-Marulanda A; Jiang HY; Kohtakangas EL
    J Gastrointest Cancer; 2018 Dec; 49(4):455-462. PubMed ID: 28702861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway.
    McLemore EC; Harnsberger CR; Broderick RC; Leland H; Sylla P; Coker AM; Fuchs HF; Jacobsen GR; Sandler B; Attaluri V; Tsay AT; Wexner SD; Talamini MA; Horgan S
    Surg Endosc; 2016 Sep; 30(9):4130-5. PubMed ID: 26659246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer.
    de Lacy FB; van Laarhoven JJEM; Pena R; Arroyave MC; Bravo R; Cuatrecasas M; Lacy AM
    Surg Endosc; 2018 May; 32(5):2442-2447. PubMed ID: 29101570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
    Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of early experience of robotic and transanal total mesorectal excision using propensity score matching.
    Law WL; Foo DCC
    Surg Endosc; 2019 Mar; 33(3):757-763. PubMed ID: 30014329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of transanal total mesorectal excision in radical surgery for rectal cancer].
    He L; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Aug; 20(8):957-960. PubMed ID: 28836258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.
    Zhang X; Gao Y; Dai X; Zhang H; Shang Z; Cai X; Shen T; Cheng X; Yu K; Li Y
    Surg Endosc; 2019 Mar; 33(3):972-985. PubMed ID: 30374790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer.
    Marks JH; Montenegro GA; Salem JF; Shields MV; Marks GJ
    Tech Coloproctol; 2016 Jul; 20(7):467-73. PubMed ID: 27178183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
    Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
    Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.
    Zeng Z; Luo S; Chen J; Cai Y; Zhang X; Kang L
    Surg Endosc; 2020 Sep; 34(9):3956-3962. PubMed ID: 31586244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Our experience with transanal total mesorectal excision (TaTME) procedures in middle and distal rectal tumors.
    Procházka V; Grolich T; Farkašová M; Čan V; Svatoň R; Svoboda M; Ostřížková L; Eid M; Frola L; Bohatá Š; Kala Z
    Rozhl Chir; 2020; 99(3):124-130. PubMed ID: 32349496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
    Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
    J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
    Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
    Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision.
    Detering R; Roodbeen SX; van Oostendorp SE; Dekker JT; Sietses C; Bemelman WA; Tanis PJ; Hompes R; Tuynman JB;
    J Am Coll Surg; 2019 Mar; 228(3):235-244.e1. PubMed ID: 30639298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.